 |
|
|
|
|
|
|
| The following information (Health Effects, Handling/Disposal, and Ingredients) is taken from the product label and/or the Material Safety Data Sheet (MSDS) prepared by the manufacturer. The National Library of Medicine does not test products nor does it evaluate information from the product label or the MSDS.
|
 |
|
|
|
Health Effects
|
|
From MSDS
IMMEDIATE CONCERNS:
- MAY BE FATAL IF SWALLOWED
- MAY BE ABSORBED THROUGH THE SKIN
- DO NOT BREATHE DUST
- DO NOT GET IN EYES, ON SKIN, OR ON CLOTHING
- KEEP OUT OF REACH OF CHILDREN
POTENTIAL HEALTH EFFECTS
EYES: Eye contact may include discomfort, tearing, swelling, redness, and blurred vision.
SKIN: This substance is not expected to cause prolonged or significant skin irritation. This substance is moderately toxic to internal organs if absorbed through the skin. The degree of injury will depend on the amount absorbed.
INGESTION: This substance is moderately toxic to internal organs if swallowed. The degree of injury will depend on the amount absorbed from the gut.
INHALATION: Breathing the dust may be irritating to the respiratory tract. If inhaled, this substance is considered practically non-toxic to internal organs.
COMMENTS HEALTH: Depending upon the extent and degree of overexposure to the product, signs and symptoms of cholinesterase inhibition can result following either ingestion, skin contact or inhalation routes of exposure. Signs and symptoms of cholinesterase inhibition can result from either acute (one time), subchronic (repeated short-term) and chronic (daily life-time) overexposure to the product.
Signs and symptoms of cholinesterase inhibition usually occur within 12 hours following overexposure. These effects may include, but may not be limited to, headache, dizziness, weakness, nausea, vomiting, diarrhea, constriction of the pupil of the eye, blurred or dark vision, excessive salivation or nasal discharge, profuse sweating and abdominal cramps. Incontinence, unconsciousness, convulsions and breathing difficulties are indicative of severe poisoning. In untreated severe poisoning, death is due to respiratory failure or cardiac arrest.
Repeated exposure may result in depletion of cholinesterase. Additional slight exposure may result in signs and symptoms.
Note to Physician: Measurement of blood cholinesterase activity may be useful in monitoring exposure. If signs of cholinesterase inhibition appear, atropine sulfate is antidotal. 2-PAM (PROTOPAM) is also antidotal and may be used in conjunction with atropine but should not be used alone.
|
From MSDS
Signs and symptoms of cholinesterase inhibition can result from either acute (one time), subchronic (repeated short-term) and chronic (daily life-time) overexposure to the product.
Signs and symptoms of cholinesterase inhibition usually occur within 12 hours following overexposure. These effects may include, but may not be limited to, headache, dizziness, weakness, nausea, vomiting, diarrhea, constriction of the pupil of the eye, blurred or dark vision, excessive salivation or nasal discharge, profuse sweating and abdominal cramps. Incontinence, unconsciousness, convulsions and breathing difficulties are indicative of severe poisoning. In untreated severe poisoning, death is due to respiratory failure or cardiac arrest.
|
From MSDS
No evidence for carcinogenic effects.
|
From MSDS
EYES: Flush eyes immediately with fresh water for at least 15 minutes while holding the eyelids open. Remove contact lenses if worn. Call a physician.
SKIN: If on skin, remove contaminated clothing, wash skin with plenty of soap and water. Wash contaminated clothing before reuse.
INGESTION: If swallowed, call a physician of Poison Control Center immediately. Drink one or two glasses of water and induce vomiting by touching the back of throat with a finger. Repeat until vomit fluid is clear. Do not induce vomiting or give anything by mouth to an unconscious or convulsing person.
INHALATION: If respiratory discomfort or irritation occurs, move the person to fresh air. See a doctor if discomfort or irritation continues.
NOTES TO PHYSICIAN: This material contains a cholinesterase inhibitor. Measurement of blood cholinesterase activity may be useful in monitoring exposure. If signs of cholinesterase inhibition appear, atropine sulfate is antidotal. 2-PAM (PROTOPAM) is also antidotal and may be used in conjunction with atropine but should not be used alone.
ADDITIONAL INFORMATION: In case of medical emergencies involving this product, call day or night, (800) 454-2333.
|
| 1 |
| 1 |
| 0 |
0 = Minimal; 1 = Slight; 2 = Moderate; 3 = Serious; 4 = Severe;
N = No information provided by manufacturer; * = Chronic Health Hazard |
| 2001-06-26 |
|
|
|
|
|
|
|
|
Handling/Disposal
|
From MSDS
GENERAL PROCEDURES: Keep pesticide in original container. Avoid contamination of feed and foodstuffs. Store in a secure cool, dry place.
ECOTOXICOLOGICAL INFORMATION: This material is toxic to aquatic organisms and should be kept out of sewage and drainage systems and all bodies of water. This material is toxic to birds and other wildlife. This pesticide is toxic to bees exposed to direct application.
|
From MSDS
The Solaris Group is committed to responsible environmental practices and recommends that all of the product be used up, carefully following all label directions and precautions.
If necessary to dispose of partially filled product container, then securely wrap it in several layers of newspaper and discard in trash.
EMPTY CONTAINER: Do not reuse empty container. Discard container in trash.
|
|
|
|
|
|
|
|
|
Ingredients from MSDS/Label
|
|
|
|
|
|
|
|
|
|
Home
| Brands | Manufacturers
| Ingredients | Health
Effects
|
|
